|
Originally published In Press as doi:10.1074/jbc.M003255200 on July 25, 2000
J. Biol. Chem., Vol. 275, Issue 40, 31061-31068, October 6, 2000
Constitutive Release of ATP and Evidence for Major Contribution
of Ecto-nucleotide Pyrophosphatase and Nucleoside Diphosphokinase
to Extracellular Nucleotide Concentrations*
Eduardo R.
Lazarowski ,
Richard C.
Boucher, and
T. Kendall
Harden
From the Departments of Medicine and Pharmacology, School of
Medicine, University of North Carolina,
Chapel Hill, North Carolina 27599
Received for publication, April 17, 2000, and in revised form, July 24, 2000
 |
ABSTRACT |
Nucleotides are important
extracellular signaling molecules. At least five mammalian P2Y
receptors exist that are specifically activated by ATP, UTP, ADP, or
UDP. Although the existence of ectoenzymes that metabolize
extracellular nucleotides is well established, the relative flux of ATP
and UTP through their extracellular metabolic products remains
undefined. Therefore, we have studied the kinetics of accumulation and
metabolism of endogenous ATP in the extracellular medium of four
different cell lines. ATP concentrations reached a maximum immediately
after change of medium and decreased thereafter with a single
exponential decay (t1/2;1 ~;230-40 min). ATP levels did not fall to zero but
attained a base-line concentration that was independent of the medium
volume and of the initial ATP concentration. Although the base-line
concentration of ATP remained stable for up to 12 h,
[ -32P]ATP added to resting cells as a radiotracer was
completely degraded within 120 min, indicating that steady state
reflected a basal rate of ATP release balanced by ATP hydrolysis
(20-200 fmol × min 1 × cell 6). High performance liquid
chromatography analysis revealed that the -phosphate of ATP was
rapidly, although transiently, transferred during steady state to
species subsequently identified as UTP and GTP, indicating the
existence of both ecto-nucleoside diphosphokinase activity and the
accumulation of endogenous UDP and GDP. Conversely, addition of
[ -32P]UTP to resting cells resulted in transient
formation of [ -32P]ATP, indicating phosphorylation of
endogenous ADP by nucleoside diphosphokinase. The final
32P-products of [ -32P]ATP metabolism were
[32P]orthophosphoric acid and a 32P-labeled
species that was further purified and identified as [32P]inorganic pyrophosphate. In C6 cells, the formation
of [32P]pyrophosphate from [ -32P]ATP at
steady state exceeded by 3-fold that of
[32P]orthophosphate. These results illustrate for the
first time a constitutive release of ATP and other nucleotides and
reveal the existence of a complex extracellular metabolic pathway for released nucleotides. In addition to the existence of an ecto-ATPase activity, our results suggest a major scavenger role of ecto-ATP pyrophosphatase and a transphosphorylating activity of nucleoside diphosphokinase.
 |
INTRODUCTION |
Extracellular nucleotides regulate a broad range of cellular
responses such as platelet aggregation, vascular tone, cell
proliferation, mucociliary clearance, cardiac and skeletal muscle
contraction, and neurotransmission (1-4). The effects of extracellular
nucleotides are mediated by two large subfamilies of receptors, the
ligand-gated channel P2X receptors (P2X1-7) and the G
protein-coupled P2Y receptors (P2Y1, 2, 4, 6, 11) (4-6).
ADP, and less potently ATP, activates the P2Y1 receptor,
while ATP and UTP are the most potent agonists at the P2Y2
receptor. In addition, ATP selectively activates the P2Y11
as well as all P2X receptors. UTP is the selective agonist for the
P2Y4 receptor,1
and UDP acts potently and selectively on the P2Y6 receptor
(7-10). The molecular identification and the wide tissue distribution of these nucleotide target proteins confirm that both adenosine and
uridine di- and triphosphates subserve important extracellular signaling roles.
ATP is known to be released in a Ca2+-dependent
manner from storage compartments in nerve terminals, chromaffin cells,
mast cells, and circulating platelets (1, 4, 11). Nucleotide release
also occurs from non-excitatory tissues, and an autocrine/paracrine function for extracellular adenine nucleotides has been proposed (2, 3,
14-22). Recent studies indicate that relatively large amounts of ATP
and UTP are released by mechanical stimulation (e.g. shear
stress, hypotonic swelling, or stretch) of epithelial and endothelial
cells, smooth muscle, glial cells, fibroblasts, and hepatocytes
(14-23), and these nucleotides in the extracellular medium promote a
robust activation of P2 receptors (16, 21, 23-25).
Ecto-nucleotidases and other ecto-enzymes metabolize extracellular ATP
and UTP (26). However, the relative functional importance of these
different enzymatic activities has not been defined for a given cell
type, and little understanding is available of how these enzymes work
in concert to produce the final pattern of metabolism of nucleotides.
This is an important question given the aforementioned different
selectivities of activation of P2Y receptors by both di- and
triphosphate adenine and uridine nucleotides. As such, we have studied
the kinetics of accumulation and metabolism of endogenous ATP in the
extracellular medium of several different cell types. Our results
illustrate for the first time a "constitutive" release of
nucleotide that balances nucleotide hydrolysis and accounts for resting
levels of extracellular nucleotides. We establish that the exchange of
the -phosphate between adenine and uridine nucleotides at steady
state markedly exceeds the ecto-ATPase activity. Moreover, our results
highlight the importance of a nucleotide pyrophosphatase activity and
reveal that this activity approaches or exceeds that of the
ecto-ATPase.
 |
MATERIALS AND METHODS |
Cell Culture and Incubations--
C6 rat glioma, 1321N1 human
astrocytoma, and 16HBE14o human bronchial epithelial
cells were grown in Dulbecco's modified Eagle's medium-H
containing 5% fetal bovine serum and antibiotics as described previously (23). ECV-304 human bladder epithelial cells (27) were grown
in Medium 199 and 10% fetal bovine serum. All cultures were grown to
confluence on 24-well plastic plates (Costar). Prior to assays, the
cultures were washed three times and incubated in 0.5 ml of serum- and
phenol red-free minimum essential medium (MEM).2
Luciferin-Luciferase Assay--
Samples of extracellular medium
were collected and boiled for 1 min, and the luciferin-luciferase assay
was performed using a LB953 AutoLumat luminometer (Berthold GmbH), as
described previously (21). Standard curves were performed routinely
using molecular biology grade ATP, which was diluted in the same buffer
and processed (e.g. boiled) in parallel to cell samples. No
loss of ATP was observed during sample boiling. The threshold value for
ATP detection was 100 pM (5 fmol/sample), and luminescence
was linear with ATP concentration to 1000 nM.
Enzymatic Synthesis of 32P-Labeled Inorganic
Pyrophosphate, [ -32P]UTP, and
[ -32P]GTP--
32P-Labeled inorganic
pyrophosphate (32PPi) was obtained by
incubating 1 µCi of [ -32P]ATP (100 µM)
with 2 units/ml commercial nucleotide pyrophosphatase at 30 °C for 5 min. The quantitative conversion of [ -32P]ATP to
32PPi plus AMP was monitored by HPLC.
[ -32P]UTP and [ -32P]GTP were obtained
by incubating 3 µCi of [ -32P]ATP (specific activity
>3000 Ci/mmol) in the presence of 0.1 units/ml bovine liver nucleoside
diphosphokinase (NDPK) and 100 nM UDP or GDP, respectively,
for 5 min at 30 °C (28).
Quantification of Nucleotides by HPLC--
Except where
indicated otherwise, species were separated by HPLC (Shimadzu) via a
Dynamax C18 column (Varian) as described previously (21). The ion
pairing mobile phase consisted of 8 mM tetrabutylammonium
hydrogen sulfate (TBAHS), 17 mM
KH2PO4, pH 5.3 (solvent A), or 8 mM
TBAHS, 100 mM KH2PO4, pH 5.3, and 10% methanol (solvent B). The mobile phase developed at 1 ml/min from
0 to 4 min in 100% solvent A, and from 4 to 30 min in 100% solvent B. The elution times of authentic nucleotides were, ATP, 23.30 min; GTP,
18.20 min; UTP, 18.15 min; CTP, 16.5 min; ADP, 14.2 min, and AMP, 6.0 min. In some experiments (Fig. 7F), an anion exchange system
with a 3021C4.6 ion chromatography column (Vydac, Hesperia, CA) was
used, and the mobile phase (2 ml/min) developed in 25 mM
NaH2PO4, pH 2.8 (solvent A), for 2 min followed by a linear gradient to 125 mM
NH2PO4, pH 2.9 (solvent B), from 2 to 10 min.
100% solvent B was maintained from 10 to 30 min. The elution times for
GTP, ATP, and UTP were 24.7, 20.3, and 16.8 min, respectively.
Absorbance at = 260 nm was monitored on-line with an SPD-10A
UV detector (Shimadzu, Japan), and radioactivity was measured on-line
with a 500TR Radiomatic analyzer (Packard, Australia), as described
previously (24). Full recovery of injected 32P counts was
routinely verified during HPLC runs.
Reagents--
ATP, UTP, GTP, and CTP were purchased from
Amersham Pharmacia Biotech (Uppsala, Sweden). UDP, ADP, GDP, CDP,
3',5'-cyclic AMP, and AMPPNP were from Roche Molecular Biochemicals.
AMPPCP and , -metATP were from RBI (Natick, MA). Bovine liver
UDP-glucose pyrophosphorylase, yeast inorganic pyrophosphatase,
Crotalus adamateus nucleotide pyrophosphatase,
yeast nucleoside diphosphokinase, firefly luciferase, luciferin,
Ap4A, Ap5A, ADP-glucose, ADP-ribose, and AMPPCP
were obtained from Sigma. [ -33P]ATP (>3000 Ci/mmol)
was from Amersham Pharmacia Biotech.
 |
RESULTS |
Extracellular Accumulation of ATP--
The kinetics of
extracellular accumulation of endogenous ATP and its metabolism were
examined with 16HBE14o human bronchial epithelial cells,
ECV-304 human bladder epithelial cells, C6 rat glioma cells, and 1321N1
human astrocytoma cells. The growth medium bathing confluent cultures
was replaced with 0.5 ml of MEM, and extracellular ATP levels were
measured by the luciferin-luciferase assay over a 12-h interval.
Consistent with ATP release secondary to mechanical stimulation of
the cells (21, 23-25), relatively large concentrations of ATP were
detected immediately after a change of medium, and these levels
decreased steadily with t1/2 values ~30-40 min
(Fig. 1 and Table
I). Extracellular levels of ATP did not
fall to zero but attained a base line in the low nanomolar range within
3 h and remained unchanged for up to 12 h (Fig. 1 and Table
I).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Decay of released ATP. Confluent
16HBE14o , ECV-304, C6, and 1321N1 cells grown in 24-well
plates were rinsed twice and incubated in 0.5 ml of serum- and phenol
red-free MEM. The medium was removed at the indicated times, and ATP
concentration was determined by the luciferase assay as described under
"Materials and Methods." The results indicate the mean ± S.D.
from at least six experiments performed with quadruplicate
samples.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
ATP decay to steady state
The t1/2 values and first order rate constants
(k) of ATP decay were obtained from the experiments
described in Fig. 1 using a non-linear regression fit for single
exponential decay (SigmaPlot, Jandel Corp.). Baseline ATP concentration
([ATP]bl) is expressed as the mean ± S.D. from 4-h
incubation samples obtained from three experiments performed in
quadruplicate. The hypothetical rate of ATP hydrolysis at steady state
( hydrolysis) was calculated as = k
[ATP]bl.
|
|
The dependence of the ATP concentration at base line on both the volume
of the extracellular medium and the magnitude of the initial
concentration of ATP was determined. The concentration of ATP 1 min
subsequent to a wash was 132 ± 19 nM
(n = 6) for ECV-304 cells incubated in 0.5 ml of
bathing solution. Addition of 1 ml of mineral oil to the post-wash
aqueous medium of these cells resulted in a slight increase of the ATP
concentration within 1 min (152 ± 25 nM,
n = 6), possibly reflecting additional ATP release due
to the higher hydrostatic pressure and/or medium stirring. Addition of
1 ml of aqueous medium instead of mineral oil (i.e. the
final volume of aqueous medium was 1.5 ml) resulted in a decrease in
ATP concentration to 46 ± 7 nM (measured at 1 min,
n = 6), consistent with the 1:3 dilution of the initial
solution. ATP concentrations further decayed to base-line levels that
were similar in non-diluted (0.5 ml of medium: 3.2 ± 1 nM, n = 6) and 1:3 diluted samples (1.5 ml
of medium: 2.6 ± 0.4 nM, n = 6). In
the four cell lines, addition of exogenous ATP (30 and 300 nM) to resting cells incubated in 0.5 ml of MEM resulted
with time in base-line ATP concentrations that were indistinguishable
from base-line values of control cells (shown in Table I). The
t1/2 values for hydrolysis of exogenous ATP (data
not shown) at both 30 and 300 nM were identical to the
t1/2 values for endogenous ATP shown in Table I.
These results indicate that extracellular ATP concentrations attain a
constant value that is independent of the volume of the bathing medium
and of the magnitude of the initial ATP concentration.
ATP Release at Steady State--
We further examined the capacity
of 16HBE14o , ECV-304, C6, and 1321N1 cells to metabolize
exogenous [ -32P]ATP added after ATP concentrations
stabilized. Cells were maintained undisturbed for at least 3 h,
[ -32P]ATP then was added at high specific
radioactivity, and both the ATP concentration and
[ -32P]ATP were quantified by the luciferin-luciferase
assay and HPLC analysis, respectively. Although levels of ATP mass
remained unchanged, [ -32P]ATP was near completely
metabolized within 120 min (Fig. 2). Thus, the development of a base-line ATP concentration reflects a
steady state where hydrolysis is balanced by basal ("constitutive") release of ATP. Consequently, resting cells release ATP at a rate that
can be quantitatively deduced from the rate of ATP hydrolysis at steady
state.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
Stable ATP concentrations co-exist with
[ -32P]ATP hydrolysis. Cells
were rinsed and pre-incubated for 3 h in 0.5 ml of MEM.
[ -32P]ATP (0.1 µCi) was added to the medium, and
samples were collected at the indicated times. The ATP concentration
was measured by the luciferase assay and the 32P-species
quantified by HPLC. The results indicate the mean value from at least
three experiments performed with triplicate (luciferase assay) or
duplicate samples (HPLC).
|
|
The simplest approach to determine the rate of ATP release at steady
state would be to measure directly the initial rate of [ -32P]ATP decay or, alternatively, the rate of
accumulation of [32P]orthophosphoric acid
(32Pi). However, disappearance of
[ -32P]ATP does not necessarily represent hydrolysis
since occurrence of enzyme-catalyzed exchange of the -phosphate
between ATP and co-released nucleotides (without involving
32Pi release) may substantially affect the
first segment of the [ -32P]ATP decay curve. Moreover,
32Pi was not the sole end-product of
[ -32P]ATP metabolism (see below). The rates of ATP
hydrolysis at steady state were deduced by kinetic analysis calculating
the first order rate constant k of ATP decay
(k = 0.693/t1/2, Table I) and using
the ATP concentrations measured at steady state
( hydrolysis = k [ATP]). The
hydrolysis values obtained ranged from ~20 to 200 fmol/min × 10 6 cells within the four cell lines studied
(Table I).
Metabolism of [ -32P]ATP--
HPLC analysis of the
products of [ -32P]ATP metabolism (Fig.
3) revealed that, in addition to
32Pi, two other 32P-species
appeared in the extracellular medium, with retention times of 8 and 18 min (hereafter referred to as 32P-8 and 32P-18,
respectively). The 32P-18 species arose soon after addition
of [ -32P]ATP and subsequently decreased in parallel
with the decrease of [ -32P]ATP (Fig.
4). The 32P-8 species
accumulated more slowly but steadily in the medium of
16HBE14o cells, ECV-304 cells, and 1321N1 cells.
Accumulation of 32P-8 was greater than accumulation of
32Pi in the medium of C6 rat glioma cells
(Figs. 3 and 4).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
Metabolism of extracellular
[ -32P]ATP. Cells were
rinsed and pre-incubated as described in the legend of Fig. 2. The HPLC
(C18 column) tracings are representative of at least three experiments
where [ -32P]ATP was incubated for 30 min in 0.5 ml of
MEM in the absence of cells (top panel) or the
presence of the indicated cells.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
Time course of extracellular
[ -32P]ATP metabolism.
[ -32P]ATP was added to resting cells for the indicated
times and the resulting 32P-species analyzed by HPLC. The
data represent the mean value from a single experiment with duplicate
samples differing by less than 20% from each other. Similar results
were obtained in at least three experiments performed under similar
conditions. Open circle,
[ -32P]ATP; open square,
32Pi; closed square,
32P-18; closed circle,
32P-8.
|
|
The metabolism of [ -32P]ATP in the medium bathing C6
cells was compared with that observed with conditioned medium obtained from these cells (Fig. 5). The formation
of 32P-8 and 32Pi was dependent on
the presence of cells. In contrast, the 32P-18 species was
generated by adding [ -32P]ATP to the cell-free
conditioned medium (Fig. 5). Similar results were observed with ECV-304
and 16HBE14o cells (data not shown).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 5.
Metabolism of
[ -32P]ATP by C6 cells and
cell-free conditioned medium. [ -32P]ATP was added
to either resting C6 cells (closed circle) or
conditioned medium obtained from resting C6 cells (open
circle), and the resulting 32P-species were
separated by HPLC. The data represent the mean ± S.D. from one
experiment performed with triplicate samples. The results are
representative of three independent experiments performed under similar
conditions.
|
|
The 32P-18 species, which co-eluted with authentic
standards of GTP and UTP (Fig.
6A), was sensitive (as was
[ -32P]ATP) to acid phosphatase, but the
32P-8 species was not (Fig. 6B). The
32P-8 species, which co-eluted with authentic
32PPi, was hydrolyzed by inorganic
pyrophosphatase, but 32P-18 and [ -32P]ATP
were not (Fig. 6C). Incubation of the
32P-species containing-samples with C. adamateus
nucleotide-pyrophosphatase (EC 3.6.1.9) resulted in conversion of both
32P-18 and [ -32P]ATP into a
32P-species that co-eluted with 32P-8 (Fig.
6D). Therefore, 32P-18 was tentatively
identified as [32P]UTP/[32P]GTP, and
32P-8 as 32PPi. These results
suggest the presence of extracellular nucleoside diphosphokinase (NDPK)
and ecto-nucleotide pyrophosphatase (E-NPP) activities.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 6.
Enzymatic identification of the
32P-8 and 32P-18 species from C6 cells.
[ -32P]ATP was added to resting C6 cells for 30 min.
The medium was removed and incubated for 5 min in the absence
(A) or in the presence of 1 unit/ml acid phosphatase
(B), inorganic pyrophosphatase (C), or nucleotide
pyrophosphatase from C. adamateus (D).
The resulting 32P-species were separated by HPLC. The
elution time of authentic standards of 32Pi,
32PPi, [ -32P]ATP,
[ -32P]UTP, and [ -32P]GTP are
indicated at the top of panel A. The
tracings are representative of at least three independent experiments
performed in duplicates.
|
|
Nucleoside Diphosphokinase--
We previously reported the
existence of an ecto-NDPK activity in 1321N1 human astrocytoma cells
(29). Unambiguous proof for NDPK-mediated formation of the
32P-18 species by 16HBE14o , ECV-304, and C6
cells was obtained by three approaches. First, addition of a molar
excess of UDP (100 µM) to cells that were pre-incubated
with [ -32P]ATP for 30 min resulted in further
conversion of [32P]ATP to [32P]UTP within 5 min (with no visible changes in the earlier 32P-species;
Fig. 7B). Similarly, addition
of 100 µM CDP resulted in a shift of the radioactivity
from both [ -32P]ATP and 32P-18 to
[ -32P]CTP (Fig. 7C), and addition of 100 µM ADP resulted in reversion of 32P-18 back
to [ -32P]ATP (data not shown). Second, cell-free
conditioned medium was deproteinized with trichloroacetic acid,
trichloroacetic acid was removed by ethyl ether extraction, and the
solutions neutralized (pH 7.4) and incubated for 10 min with
[ -32P]ATP (3 nM) in the absence or
presence of 0.05 units/ml bovine liver NDPK. No changes in
[ -32P] ATP were observed in the absence of NDPK,
confirming that no endogenous activity was present after the
trichloroacetic acid extraction. Inclusion of NDPK during incubation
resulted in partial conversion of [ -32P]ATP to
32P-18 (Fig. 7D). Thus, the endogenous
transphosphorylating activity that promotes formation of the
32P-18 species in the cell-bathing medium could be substituted
by exogenous NDPK added to the deproteinized solutions. Third, the 32P-18 species that co-elute as UTP and GTP on the C18
column (Fig. 7E) were resolved as [32P]UTP
(~45%) and [32P]GTP (55%), respectively, by an ion
chromatography column (Fig. 7F).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 7.
NDPK promotes the formation of
[ -32P]UTP and
[ -32P]GTP. Resting C6 cells
were incubated for 30 min with [ -32P]ATP
(A), after which 100 µM UDP (B) or
CDP (C) were added for 5 min. Conditioned medium from C6
cells was deproteinized with trichloroacetic acid and subsequently
incubated for 30 min with 0.1 µCi of [ -32P]ATP and
0.1 units/ml nucleoside diphosphokinase (D). The HPLC
tracings are representative of at least two experiments performed in
duplicate. In a separate experiment, resting C6 cells were incubated
for 10 min with [ -32P]ATP and the resulting species
separated by HPLC via a C18 (E) or an ion exchange column
(F). The data are representative of two independent
experiments. The elution times of 32P-labeled nucleotide
standards are indicated. Similar results were obtained with
16HBE14o and ECV-304 cells (data not shown).
|
|
These findings indicate that endogenous GDP and UDP accumulate in the
extracellular medium and serve as acceptor substrates of NDPK. This
notion also applies for ADP, as is shown below.
Nucleotide Pyrophosphatase--
The 32P-8 species was
purified from C6 cell medium by HPLC (Fig.
8, A and B) and
positively identified as 32PPi by incubating
the purified fraction with 2 units/ml UDP-glucose pyrophosphorylase and
a molar excess of UDP-glucose. Consistent with the reaction:
PPi + UDP-glucose UTP + glucose-1P (23), full
conversion of the 32P-8 species into [32P]UTP
was achieved under these conditions (Fig. 8C).

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 8.
Identification of
32PPi. C6 cells were incubated for 30 min
in the presence of 1 µCi of [ -32P]ATP in 0.5 ml of
MEM (A). The 32P-8 species was purified and
further incubated for 1 h with 1 mM UDP-glucose in the
absence (B) or in the presence (C) of 2 units/ml
UDP-glucose pyrophosphorylase (21). The formation of
[32P]UTP was monitored by HPLC. The completeness of the
reaction was confirmed in a parallel incubation where authentic
32PPi was quantitatively converted to
[32P]UTP. D, HPLC tracings corresponding to a
2-h incubation of C6 (  ), 16HBE14o (- - -), or
ECV-304 ( ... ) cells with 0.5 µCi of
32PPi.
|
|
Since different ratios of extracellular 32PPi
versus 32Pi were observed with the
different cell types studied, the possibility that an extracellular
inorganic pyrophosphatase activity was differentially expressed in a
cell-specific manner was examined. C6, 16HBE14o , and
ECV-304 cells were incubated in the presence of
32PPi, and the resulting species accumulating
in the medium were analyzed by HPLC. Surprisingly,
32PPi remained unchanged for up to 120 min
after its addition (Fig. 8), indicating that inorganic pyrophosphatase
is not expressed on the surface of these cells. These results suggest
that the relative ratio of accumulation of PPi over
Pi is determined exclusively by the relative activities of
E-NPP versus ecto-ATPase.
32PPi also was the major end product of [
-32P]UTP on C6 cells (Fig.
9). Interestingly, the terminal phosphate
of UTP was transiently (although not completely) transferred to ATP
(Fig. 9), consistent with phosphorylation of endogenous ADP by
endogenous NDPK. Since formation of 32PPi
further proceeded after 20 min while [32P]ATP was no
longer detected (Fig. 9), we conclude that UTP is itself an efficient
substrate for the formation of pyrophosphate.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 9.
Metabolism of
[ -32P]UTP on C6 cells. C6
cells were incubated in 0.5 ml of MEM containing 0.1 µCi of
[ -32P]UTP. A, HPLC tracings representative
of t = 0 and 10-min incubation periods. B,
time course of 32P-species accumulation. The data represent
the mean value of two experiments performed with duplicate samples that
differed by less than 20% from each other.
|
|
Ecto-nucleotide pyrophosphatases hydrolyze dinucleoside polyphosphates
and nucleotide sugars, but also generate free pyrophosphate (and AMP)
from ATP (26). Therefore, these enzymes are logical candidates for the
ATP pyrophosphatase activity described in this study. Although we have
not measured the direct conversion of ATP to AMP as proof of principle
for E-NPP activity, conversion of [ -32P]ATP to
32PPi was effectively prevented by the E-NPP
inhibitor , -metATP (Fig. 10) and
was delayed by Ap4A, Ap5A, UDP-glucose,
ADP-glucose, ADP-ribose, AMPPCP, and AMPPNP (Fig. 10), all of which are
known substrates of the E-NPP family.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 10.
Effect of nucleotide analogues on the
formation of 32PPi. Resting C6 cells were
incubated for the times indicated in the presence of 100 µM indicated nucleotide and 0.1 µCi of
[ -32P]ATP (specific activity >3000 Ci/mmol), and the
resulting 32PPi was quantified by HPLC. The results are
expressed as the percentage of radioactivity accumulated as
32PPi relative to initial
[ -32P]ATP. The data represent the mean value from two
different experiments performed with duplicate samples that differed by
less than 10% from each other.
|
|
The kinetic constants for the ATP-dependent accumulation
of 32PPi and 32Pi
on C6 cells were calculated (Table II).
Although Vmax values for PPi
formation were about one half of those for Pi, the
PPi-generating activity exhibited a
Km(app) for ATP that was approximately 6 times lower than the Km(app) of the
ecto-ATPase activity. Thus, at steady state where [ATP]
Km, the formation of PPi on C6 cells
exceeds by a factor of 3 that of Pi (determined by the
Vmax/Km ratios) suggesting
that E-PPN activity is the major regulator of the extracellular levels
of nucleotides that are released by resting cells. This conclusion also
is consistent with the results described earlier (Fig. 3), which
illustrated that accumulation of 32PPi at
steady state on resting C6 cells was 3-4 times higher than accumulation of 32Pi. The
Vmax/Km values for the
overall ATP hydrolysis reaction on C6 cells (~0.03
min 1; Table II) closely approached the first
order rate constant value (k = 0.02 min 1) calculated from the
t1/2 values, as detailed in Fig. 1 and Table I.
View this table:
[in this window]
[in a new window]
|
Table II
Michaelis-Menten constants for Pi and PPi formation
during ATP hydrolysis on C6 cells
C6 cells were incubated at various times with increasing concentrations
of ATP (1-2000 µM) in the presence of 0.1 µCi of
[ -32P]ATP. The formation of 32Pi and
32PPi was quantified by HPLC. The kinetic constants
were deduced using Hanes-Woolf plots.
|
|
 |
DISCUSSION |
In the present study, we demonstrated that basal (or
"constitutive") release of ATP is a characteristic of resting
cells, and we have defined conditions that allow quantification of the basal rate of ATP release. Both mechanically released ATP and exogenous
ATP decay to a steady state where the magnitude of nucleotide hydrolysis and basal release are balanced. At steady state,
extracellular ATP concentrations are independent of both the volume of
the extracellular solution and the initial ATP input. Thus, ATP
concentrations in the extracellular medium of resting cells are an
intrinsic attribute of the tissue and reflect a balance between the
capacity of the cells to release ATP "constitutively," and the
efficiency of the ATP-hydrolyzing ecto-enzymes.
The basal rate of ATP release was determined based on bulk ATP
concentrations. However, ATP concentrations measured in the entire
medium are unlikely to accurately reflect the concentration at the cell
surface. ATP and UTP levels observed in the medium bathing resting
1321N1 cells (Table I and Refs. 23 and 25) are below threshold values
for stimulation of P2Y receptors (24, 25). However, addition of apyrase
or hexokinase to resting P2Y2 or P2Y4
receptor-expressing 1321N1 cells resulted in significant reduction of
the basal accumulation of inositol phosphates (21, 24, 25), suggesting
that local nucleotide concentrations were high enough to confer basal
activity to these receptors. These results indicate that quantification
of ATP and UTP in the bulk medium likely reflects a fraction of the
actual nucleotide mass that accumulates transiently in the vicinity of
the P2Y receptors. Consistent with this notion, using an in
situ assay for ATP whereby cell surface-bound luciferase acts as a
bioluminescent sensor for ATP, Dubyak and colleagues (30) recently
reported that ATP concentrations in the bulk medium of
thrombin-stimulated platelets underestimate by at least 1 order of
magnitude the ATP concentration near the cell surface.
"Constitutive" release of ATP may be physiologically relevant
particularly in tissues such as human airways, which are covered by a
thin layer (~1 µl/cm (Ref. 2)) of surface liquid (31). The
P2Y2 receptor of airways controls several components of
mucociliary clearance by promoting
Ca2+-dependent Cl secretion,
mucin secretion, and ciliary beating (31-35). Based on the observed
rate of ATP release from resting 16HBE14o cells (Table
I), accumulation of ATP in the periciliar airway surface liquid would
proceed at a rate of ~20 nM/min, and ATP accumulation
would rapidly exceed EC50 values for P2Y2
receptor activation if substantial metabolism of nucleotide did not
occur. We speculate that basal release of ATP provides a mechanism of activation of the P2Y2 receptor that controls physiological
functions in "resting" airways.
We reported recently that nucleotide release by mechanically stimulated
cells, which represented 0.5-10% of the intracellular pool (21,
23-25), was not associated with cell damage (assayed by LDH activity,
51Cr release, or with the fluorescent probe calcein (21,
23-25)). Resting cells release one millionth of the total cellular ATP (23) per minute, a value far below the sensitivity of available assays
for cell lysis. Thus, our data do not rule out the possibility that
ongoing irreversible membrane damage of a very small number of cells
may contribute to the observed rates of ATP release. However,
increasing evidence suggests that release of cytosolic ATP is a
cell-regulated process (4, 16, 22, 36, 37), which may involve the
action of glibenclamide-sensitive K+ channels (16),
5-nitro-2-(3phenylpropylamino)benzoic acid-sensitive Cl
channels (22, 37), and/or phosphatidylinositol 1,4,5-trisphosphate kinase (36). It has been speculated that ATP release occurs via members
of the ABC transporter family of proteins such as the cystic fibrosis
transmembrane regulator (38, 39), but this notion was not sustained by
a number of studies including experiments with cystic fibrosis
transmembrane regulator-deficient cells in experiments where cystic
fibrosis transmembrane regulator was overexpressed in cells where the
P2Y2 receptor acted as a biosensor for ATP/UTP release (22,
27, 37, 40). Although the mechanism whereby non-excitatory cells
release nucleotides remains unclear, basal ATP release occurs at
negligible rates compared with cellular ATP turnover and, thus, may
provide a "purinergic tone" to non-excitatory tissues without
compromising the energetic balance of the cells.
The present study also illustrates the complexity of the cellular
pathways involved in the regulation of extracellular nucleotide levels.
Our results indicate that an extracellular NDPK activity is responsible
for the continuous and reversible interchange of -phosphate within
endogenous nucleotides. This NDPK activity is so large that transfer of
[ -32P]phosphate from ATP to both GTP and UTP was
detected in all cell types prior to measurable accumulation of
32PPi or 32Pi. These
data are consistent with our previous kinetic analysis of NDPK and
nucleotidase activities on 1321N1 cells (29), which indicated that NDPK
activity exceeded by a factor of 20 that of the ecto-nucleotidase (29).
To our knowledge, this is the first observation of ecto-NDPK activity
that plays an active role in the forward and reverse transfer of the
terminal phosphate of endogenous ATP to other endogenous nucleotides,
e.g. UDP. Our results are not only consistent with our
previous observation of extracellular accumulation of UTP (22, 25) but
also indicate that UDP, ADP, and GDP accumulate in amounts comparable
to those of triphosphonucleotides. Recently, we have observed that ADP concentrations in the medium of resting C6, 16HBE14o ,
ECV-304, and 1321N1 cells were at least 5 times higher than ATP
concentrations at steady state (41). Although the present study cannot
rule out the possibility that ADP and other nucleoside diphosphates are
co-released with NTPs, our previous observations with
[3H]adenine-labeled 1321N1 astrocytoma and human nasal
epithelial cells indicated that accumulation of extracellular
[3H]ADP is secondary to [3H]ATP release and
hydrolysis (21, 24). Further, studies of [3H]ADP
metabolism on the cells used in this study showed gradual conversion to
[3H]AMP and [3H]ADO without measurable
formation of [3H]ATP, indicating that synthesis of ATP
via an ecto-adenylate kinase activity did not
occur.3 Additionally, absence
of adenylate kinase activity during steady state measurements was
supported by the fact that no formation of [32P]ADP was
detected following the addition of [32P]ATP to resting
cells (Figs. 3 and 4). The NDPK activity not only establishes a
constant ratio between the triphosphate nucleotide signaling molecules,
but also provides an extracellular ATP regenerating system under
conditions where the high energy phosphate bond of ATP is selectively
consumed, e.g. during phosphorylation of extracellular proteins (4).
Our data indicate two extracellular pathways for ATP hydrolysis at
steady state. Accumulation of orthophosphate along with the higher
levels of extracellular nucleoside diphosphates relative to
triphosphates (as discussed above) suggests an ecto-nucleotidase activity with preference for NTPs over NDPs, i.e. CD39-L1.
However, 32PPi is the major end product of
[ -32P]ATP hydrolysis in C6 cells, and it accumulates
significantly on ECV-304, 16HBE14o , and 1321N1 cells.
Since the observed Km value for PPi formation on C6 cells was ~6 times smaller than Km
values for Pi formation (Table II), we speculate that the
PPi-generating activity (likely E-NPP) might be important
for controlling the net NTP concentrations while the CD39-L1 activity
determines the relative amounts of NTP versus NDP at steady
state. A recent study suggested that PC-1 hydrolyzes ATP on C6 cells
(42). Whether this E-PPN is responsible for the ATP/UTP pyrophosphatase
activity described in the present study and whether additional
mechanisms are involved in the formation of PPi remain to be determined.
The biological significance of extracellular ATP and UTP has been
supported in recent years by direct demonstration of their release and
by pharmacological studies of P2 receptors that are potently stimulated
by these nucleotides. However, a subset of the cloned P2Y receptors,
i.e. P2Y1 and P2Y6 receptors, and a yet to be cloned Gi/adenylyl cyclase-coupled P2Y receptor
are specifically activated by nucleoside diphosphates. The concerted action of ecto-ATPases, which convert NTP to NDP, and ecto-NTP pyrophosphatases, which hydrolyze NTP to AMP bypassing the formation of
NDP, offers a control mechanism for the autocrine activation of
P2Y1 and P2Y6 receptors. Our data support the
idea that nucleotide release, accumulation, and interconversion are
integrated components of resting cells.
 |
ACKNOWLEDGEMENTS |
We are indebted to Catharina van Heusden and
Todd Listwa for technical assistance and to Jose L. Boyer for helpful discussions.
 |
FOOTNOTES |
*
This work was supported by Cystic Fibrosis Foundation
Grant Lazaro99G0 and by National Institutes of Health Grants GM38213 and HL34322.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: CB 7248, 7017 Thurston-Bowles Bldg., Dept. of Medicine, University of North Carolina, Chapel Hill NC 27599-7248. E-mail:
eduardo_lazarowski@med.unc.edu.
Published, JBC Papers in Press, July 25, 2000, DOI 10.1074/jbc.M003255200
1
ATP is not an agonist at the human
P2Y4 receptor but is a potent agonist at the rat
P2Y4 homologue (11, 12).
3
E. Lazarowski, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
MEM, minimal
essential medium;
PPi, inorganic pyrophosphate;
AMPPNP, adenylyl imidodiphosphate;
AMPPCP, , -methylene ATP;
, -metATP, , -methylene ATP;
NDPK, nucleoside
diphosphokinase;
Ap4A, P1-P4-di(adenosine-5') tetraphosphate;
Ap5A, P1-P5-di(adenosine-5') tetraphosphate;
HPLC, high performance liquid chromatography;
TBAHS, tetrabutylethyl ammonium
sulfate;
E-NPP, ecto-nucleotide pyrophosphatase.
 |
REFERENCES |
| 1.
|
Burnstock, G.,
and Kennedy, C.
(1985)
Gen. Pharmacol.
16,
433-440
|
| 2.
|
Gordon, J. L.
(1986)
Biochem. J.
233,
309-319
|
| 3.
|
Dubyak, G. R.,
and El-Moatassim, C.
(1993)
Am. J. Physiol.
265,
C577-C606
|
| 4.
|
Burnstock, G.
(1998)
in
The P2 Nucleotide Receptors
(Turner, J. T.
, Weisman, G. A.
, and Fedan, J. S., eds)
, pp. 3-42, Humana Press, Totowa, NJ
|
| 5.
|
Valera, S.,
Hussy, N.,
Evans, R. J.,
Adami, N.,
North, R. A.,
Surprenant, A.,
and Buell, G.
(1994)
Nature
371,
516-5519
|
| 6.
|
King, B. F.,
Townsend-Nicholson, A.,
and Burnstock, G.
(1998)
Trends Pharmacol. Sci.
19,
506-514
|
| 7.
|
Fredholm, B. B.,
Abbracchio, M. P.,
Burnstock, G.,
Dubyak, G. R.,
Harden, T. K.,
Jacobson, K. A.,
Schwabe, U.,
and Williams, M.
(1997)
Trends Pharmacol. Sci.
18,
79-82
|
| 8.
|
Evans, R. J.,
Surprenant, A.,
and North, R. A.
(1998)
in
The P2 Nucleotide Receptors
(Turner, J. T.
, Weisman, G. A.
, and Fedan, J. S., eds)
, pp. 43-62, Humana Press, Totowa, NJ
|
| 9.
|
Communi, D.,
Govaerts, C.,
Parmentier, M.,
and Boeynaems, J. M.
(1997)
J. Biol. Chem.
272,
31969-31973
|
| 10.
|
Harden, T. K.,
Nicholas, R. A.,
Schachter, J. B.,
Lazarowski, E. R.,
and Boyer, J. L.
(1998)
in
The P2 Nucleotide Receptors
(Turner, J. T.
, Weisman, G. A.
, and Fedan, J. S., eds)
, pp. 109-134, Humana Press, Totowa, NJ
|
| 11.
|
Bogdanov, Y. D.,
Wildman, S. S.,
Clements, M. P.,
King, B. F.,
and Burnstock, G.
(1998)
Br. J. Pharmacol.
124,
428-433
|
| 12.
|
Webb, T. E.,
Henderson, D, J.,
Roberts, J. A.,
and Barnard, E. A.
(1998)
J Neurochem.
71,
1348-1357
|
| 13.
|
Todorov, L. D.,
Mihaylova-Todorova, S.,
Craviso, G. L.,
Bjur, R. A.,
and Westfall, D. P.
(1996)
J. Physiol.
496,
731-748
|
| 14.
|
Hassessian, H.,
Bodin, P.,
and Burnstock, G.
(1993)
Br. J. Pharmacol.
109,
466-472
|
| 15.
|
Saiag, B.,
Bodin, P.,
Shacoori, V.,
Catheline, M.,
Rault, B.,
and Burnstock, G.
(1995)
Endothelium
2,
279-285
|
| 16.
|
Schlosser, S. F.,
Burgstahler, A. D.,
and Nathanson, M. H.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9948-9953
|
| 17.
|
Wang, Y.,
Roman, R.,
Lidofsky, S. D.,
and Fitz, J. G.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12020-12025
|
| 18.
|
Ferguson, D. R.,
Kennedy, I.,
and Burton, T. J.
(1997)
J. Physiol.
505,
503-511
|
| 19.
|
Mitchell, C. H.,
Carre, D. A.,
McGlinn, A. M.,
Stone, R. A.,
and Civan, M. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7174-7178
|
| 20.
|
Hamada, K.,
Takuwa, N.,
Yokoyama, K.,
and Takuwa, Y.
(1998)
J. Biol. Chem.
273,
6334-6340
|
| 21.
|
Watt, W. C.,
Lazarowski, E. R.,
and Boucher, R. C.
(1998)
J. Biol. Chem.
273,
14053-14058
|
| 22.
|
Hazama, A.,
Shimizu, T.,
Ando-Akatsuka, Y.,
Hayashi, S.,
Tanaka, S.,
Maeno, E.,
and Okada, Y.
(1999)
J. Gen. Physiol.
114,
525-533
|
| 23.
|
Lazarowski, E. R.,
and Harden, T. K.
(1999)
Br. J. Pharmacol.
127,
1272-1278
|
| 24.
|
Lazarowski, E. R.,
Watt, W. C.,
Stutts, M. J.,
Boucher, R. C.,
and Harden, T. K.
(1995)
Br. J. Pharmacol.
116,
1619-1627
|
| 25.
|
Lazarowski, E. R.,
Homolya, L.,
Boucher, R. C.,
and Harden, T. K.
(1997)
J. Biol. Chem.
272,
24348-24354
|
| 26.
|
Zimmermann, H.
(1996)
Drug Dev. Res.
39,
337-352
|
| 27.
|
Brown, J.,
Reading, S. J.,
Jones, S.,
Fitchett, C. J.,
Howl, J.,
Martin, A,
Longland, C. L.,
Michelangeli, F.,
Dubrova, Y. E.,
and Brown, C. A
(2000)
Lab. Invest.
80,
37-45
|
| 28.
|
Lazarowski, E. R.,
Watt, W. C.,
Stutts, M. J.,
Brown, H. A.,
Boucher, R. C.,
and Harden, T. K.
(1996)
Br. J. Pharmacol.
117,
203-209
|
| 29.
|
Lazarowski, E. R.,
Homolya, L.,
Boucher, R. C.,
and Harden, T. K.
(1997)
J. Biol. Chem.
272,
20402-20407
|
| 30.
|
Beigi, R.,
Kobatake, E.,
Aizawa, M.,
and Dubyak, G. R.
(1999)
Am. J. Physiol.
276,
C267-C278
|
| 31.
|
Boucher, R. C.
(1999)
J. Physiol.
516,
631-638
|
| 32.
|
Davis, C. W.,
Dowell, M. L.,
Lethem, M. I.,
and Van Scott, M.
(1992)
Am. J. Physiol.
262,
C1313-C1323
|
| 33.
|
Lethem, M. I.,
Dowell, M. L.,
Van Scott, M.,
Yankaskas, J. R.,
Egan, T.,
Boucher, R. C.,
and Davis, C. W.
(1993)
Am. J. Respir. Cell Mol. Biol.
9,
315-322
|
| 34.
|
Villalon, M.,
Hinds, T. R.,
and Verdugo, P.
(1989)
Biophys. J.
56,
1255-1258
|
| 35.
|
Korngreen, A.,
and Priel, Z.
(1996)
J. Physiol.
497,
53-66
|
| 36.
|
Feranchak, A. P.,
Roman, R. M.,
Schwiebert, E. M.,
and Fitz, J. G.
(1998)
J. Biol. Chem.
273,
14906-14911
|
| 37.
|
Mitchell, C. H.,
Carre, D. A.,
McGlinn, A. M.,
Stone, R. A.,
and Civan, M. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7174-7178
|
| 38.
|
Schwiebert, E, M.,
Egan, M. E.,
Hwang, T, H.,
Fulmer, S. B.,
Allen, S. S.,
Cutting, G. R.,
and Guggino, W. B.
(1995)
Cell
81,
1063-1073
|
| 39.
|
Roman, R. M.,
Wang, Y.,
Lidofsky, S. D.,
Feranchak, A. P.,
Lomri, N.,
Scharschmidt, B. F.,
and Fitz, J. G.
(1997)
J. Biol. Chem.
272,
21970-21976
|
| 40.
|
Grygorczyk, R.,
and Hanrahan, J. W.
(1997)
Am. J. Physiol.
272,
C1058-C1066
|
| 41.
|
Lazarowski, E. R.,
Boucher, R. C.,
and Harden, T. K
(2000)
in
Ecto-ATPases and Related Ectonucleotidases
(Vanduffel, L.
, and Lemmens, R., eds)
, pp. 283-294, Shaker Publishing BV, Maastricht, The Netherlands
|
| 42.
|
Grobben, B.,
Anciaux, K.,
Roymans, D.,
Stefan, C.,
Bollen, M.,
Esmans, E. L.,
and Slegers, H.
(1999)
J. Neurochem.
72,
826-834
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. E. Wolk, E. R. Lazarowski, Z. P. Traylor, E. N. Z. Yu, N. A. Jewell, R. K. Durbin, J. E. Durbin, and I. C. Davis
Influenza A Virus Inhibits Alveolar Fluid Clearance in BALB/c Mice
Am. J. Respir. Crit. Care Med.,
November 1, 2008;
178(9):
969 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|